It may seem like an unlikely link but the body’s response to arthritis may hold answers for better cancer drugs, says Luis Voloch, chief technology officer of startup Immunai. Immune cells respond to both conditions, but in different ways. Insights into the response for one disease could inform the treatment of the other, he says.
“We believe that the right way to understand many diseases, and specifically diseases that have an immune component, is by looking at all of them at once or from the top down,” says Voloch (pictured above, left).
Immunai aims to provide that broader view with a… Read more »
UNDERWRITERS AND PARTNERS